Does LEUPROLIDE Cause Injection site swelling? 224 Reports in FDA Database
Prostate Health & Male Vitality — Naturally
ProstaVive: better flow, better sleep, better energy. 180-day guarantee.
According to the FDA Adverse Event Reporting System (FAERS), 224 reports of Injection site swelling have been filed in association with LEUPROLIDE (Fensolvi). This represents 0.3% of all adverse event reports for LEUPROLIDE.
224
Reports of Injection site swelling with LEUPROLIDE
0.3%
of all LEUPROLIDE reports
3
Deaths
19
Hospitalizations
How Dangerous Is Injection site swelling From LEUPROLIDE?
Of the 224 reports, 3 (1.3%) resulted in death, 19 (8.5%) required hospitalization, and 1 (0.4%) were considered life-threatening.
Is Injection site swelling Listed in the Official Label?
This adverse event is not currently listed in the official FDA drug label for LEUPROLIDE. However, 224 reports have been filed with the FAERS database.
What Other Side Effects Does LEUPROLIDE Cause?
Hot flush (9,146)
Death (8,772)
Intercepted product preparation error (8,621)
Syringe issue (7,847)
Device leakage (5,861)
Wrong technique in product usage process (5,062)
Fatigue (4,805)
Injection site pain (4,678)
Prostatic specific antigen increased (2,432)
Asthenia (2,176)
What Other Drugs Cause Injection site swelling?
ETANERCEPT (9,992)
DUPILUMAB (9,582)
ADALIMUMAB (4,428)
EVOLOCUMAB (1,933)
GLATIRAMER (1,836)
IXEKIZUMAB (1,615)
TIRZEPATIDE (1,131)
ENBREL (1,121)
HYDROXYPROGESTERONE CAPROATE (924)
HUMIRA (838)
Which LEUPROLIDE Alternatives Have Lower Injection site swelling Risk?
LEUPROLIDE vs LEVALBUTEROL
LEUPROLIDE vs LEVAMISOLE
LEUPROLIDE vs LEVAQUIN
LEUPROLIDE vs LEVEMIR
LEUPROLIDE vs LEVETIRACETAM